ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Radiopharm Theranostics Limited

Radiopharm Theranostics Limited (RAD)

0,02
0,001
(5,26%)
Geschlossen 06 Juni 8:00AM

Radiopharm Theranostics Limited (RAD) Aktie

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Wichtige Statistiken und Details

Current Price
0,02
( 5,26% )
Gebot
0,02
Fragen
0,021
Volumen
4.679.285
0,019 Tagesbereich 0,0205
0,017 52-Wochen-Bereich 0,04
Marktkapitalisierung
Handelsende
0,019
Handelsbeginn
0,02
Letzte Trade
200000
@
0.02
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
AUD 2.733.824
Ausgegebene Aktien
3.544.216.160
Dividendenrendite (LTM)
Kurs-Gewinn-Verhältnis
-1,05
Gewinn pro Aktie (EPS)
-0,02
Erlöse (LTM)
16,28M
Nettogewinn (LTM)
-46,58M

Über Radiopharm Theranostics Limited

Radiopharm Theranostics Limited a clinical-stage radiotherapeutics company, engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical needs. The company develops several products, including RAD101, a pivalate brain me... Radiopharm Theranostics Limited a clinical-stage radiotherapeutics company, engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical needs. The company develops several products, including RAD101, a pivalate brain metastasis diagnostic; RAD102, a pivalate therapeutic; RAD201a, a Nano-mAb HER-2 breast diagnostic; RAD202, a Nano-mAb HER-2 breast therapeutic; RAD203, a Nano-mAb PDL1 non-small cell lung diagnostic; and RAD204, a Nano-mAb PDL1 non-small cell lung therapeutic. Additionally, it is developing RAD301 and RAD302, which are Avß6-Integrin pancreatic diagnostic and therapeutic products; RAD401, a PSA-mAb prostate cancer diagnostic; RAD402, a PSA-mAb prostate cancer therapeutic; RAD601, a PTPµ glioblastoma diagnostic; and RAD602, a PTPµ glioblastoma therapeutic. The company has a strategic agreement with Lantheus Holdings, Inc. to advance the clinical development of radiopharmaceuticals. The company was incorporated in 2021 and is based in Carlton, Australia. Mehr anzeigen

Sektor
Healthcare
Branche
Biotechnology & Life Sciences
Hauptsitz
Carlton, Australia
Gegründet
2026
Radiopharm Theranostics Limited is listed in the Healthcare sector of the Australische Börse with ticker RAD. The last closing price for Radiopharm Theranostics was AUD0,02. Over the last year, Radiopharm Theranostics shares have traded in a share price range of AUD 0,017 to AUD 0,04.

Radiopharm Theranostics currently has 3.544.216.160 shares in issue. The market capitalisation of Radiopharm Theranostics is AUD70,88 million. Radiopharm Theranostics has a price to earnings ratio (PE ratio) of -1.05.

RAD Neueste Nachrichten

Keine Nachrichten vorhanden.
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1000.020.0210.01918837270.0199163DE
40.00052.56410256410.01950.0220.01819367250.02005948DE
12-0.002-9.090909090910.0220.0240.01826267840.02033759DE
26-0.002-9.090909090910.0220.0370.01764701610.0246079DE
52-0.007-25.92592592590.0270.040.01754857450.02555819DE
156-0.115-85.18518518520.1350.1550.01738947870.02938402DE
260-0.45-95.74468085110.470.4950.01728149940.04561796DE

RAD - Frequently Asked Questions (FAQ)

What is the current Radiopharm Theranostics Limited share price?
The current share price of Radiopharm Theranostics Limited is AUD 0,02
How many Radiopharm Theranostics Limited shares are in issue?
Radiopharm Theranostics Limited has 3.544.216.160 shares in issue
What is the market cap of Radiopharm Theranostics Limited?
The market capitalisation of Radiopharm Theranostics Limited is AUD 70,88M
What is the 1 year trading range for Radiopharm Theranostics Limited share price?
Radiopharm Theranostics Limited has traded in the range of AUD 0,017 to AUD 0,04 during the past year
What is the PE ratio of Radiopharm Theranostics Limited?
The price to earnings ratio of Radiopharm Theranostics Limited is -1,05
What is the cash to sales ratio of Radiopharm Theranostics Limited?
The cash to sales ratio of Radiopharm Theranostics Limited is 4,35
What is the registered address of Radiopharm Theranostics Limited?
The registered address for Radiopharm Theranostics Limited is 62 Lygon Street, Carlton, Victoria, 3053
What is the Radiopharm Theranostics Limited website address?
The website address for Radiopharm Theranostics Limited is www.radiopharmtheranostics.com
Which industry sector does Radiopharm Theranostics Limited operate in?
Radiopharm Theranostics Limited operates in the Biotechnology & Life Sciences sector

RAD Trades

Mehr

Trades verzögert

Um Echtzeit-Trades zu erhalten, aktualisieren Sie Ihr Konto

Auf Echtzeit aktualisieren
Keine Diskussionen Gefunden.
Neuen Thread Erstellen